Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 1/2 1

Status

Recruiting 5Completed 2Not yet recruiting 1

Sponsor Class

OTHER 5

Study Type

Interventional 3Observational 2

Sponsor

Cancer Type

Head & Neck 3Thoracic 2Genitourinary 1Gastrointestinal 1Dermatologic 1Breast 1

Conditions

Nasopharyngeal Carcinoma 2Carcinoma, Non-Small-Cell Lung 2Squamous Cell Carcinoma of Head and Neck 1Neoplasm Metastasis 1Melanoma 1Lung Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Specimen Handling 116pembrolizumab 112Magnetic Resonance Spectroscopy 99Carboplatin 83Cyclophosphamide 70Biopsy 63Cisplatin 59Paclitaxel 56Bevacizumab 56Gemcitabine 48Nivolumab 45fludarabine 39Dexamethasone 37atezolizumab 36Rituximab 36Pemetrexed 36Fluorouracil 36Docetaxel 35Leucovorin 32Doxorubicin 31venetoclax 30Radiotherapy 30Oxaliplatin 29Capecitabine 29Temozolomide 27Prednisone 26Cetuximab 26130-nm albumin-bound paclitaxel 25Standard of Care 24Letrozole 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Recruiting × Immune Checkpoint Inhibitors × 30 days × Clear all
NCT07590024 2026-06-04

RAIRI-NPC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 3 Recruiting
651 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT07359040 2026-06-03

Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer

Peking University People's Hospital

Recruiting
80 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07618078 2026-06-03

Real-World RAIRI-Guided Risk Stratification for Adjuvant Therapy Benefit After Chemoradiotherapy in NPC

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Recruiting
900 enrolled
Head & Neck

Nasopharyngeal Carcinoma

NCT07405086 2026-05-22

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

OHSU Knight Cancer Institute

Phase 4 Recruiting
160 enrolled
DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT06502691 2026-05-19

[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients With Metastatic Breast Cancer

University of Washington

Phase 1/2 Recruiting
22 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡